National Cancer Centre Singapore

Last week, the Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group held its 6th Scientific Symposium of the Singapore Liver Cancer Consortium (SLCC). Key opinion leaders from 14 countries and over 100 participants from local academic institutions and industry gathered in NCCS to engage in a rich sharing and networking session. Professor Pierce Chow, PI of the Programme in Translational and Clinical Liver Cancer Research at NCCS and protocol chair of the AHCC Trials Group, opened the symposium during which insightful discussions were led by presenters from Singapore, Hong Kong and Japan. The AHCC Trials Group, which held its annual meeting alongside the SLCC scientific symposium, was set up in 1997 to conduct multi-centre clinical trials and research studies to improve treatment offerings for the primary liver cancer, hepatocellular carcinoma.

In a major boost for cancer care and research, the Singapore Translational Cancer Consortium announced its entry into the Roche and Genentech imCORE Network of 27 leading cancer research institutions worldwide, yesterday. STCC leads a coalition of public healthcare institutions in Singapore, including the National Cancer Centre Singapore, joining this prestigious network. Assoc Prof Daniel SW Tan, NCCS’ Head Division of Clinical Trials and Epidemiological Sciences, who was a panellist at the event, shared that the global network highlights the importance of close collaboration in cancer research and enables Singapore oncology researchers and clinician-scientists to tap onto the Network to share best practices and ideas, with the goal of driving immune-oncology research and development globally. #healthcare #translational #immunotherapy #NationalCancerCentreSingapore #collaboration

So proud of our Nurse Clinician, Sylvia Goh who received the MOH Nurses’ Merit Award 2024! The award recognises nurses who have displayed exceptional performance and contributed to raising the profession. Congratulations Sylvia! 🎉👏🏼

🌍 From extreme weather to infectious diseases, climate change is reshaping our health and healthcare systems. Learn how the Centre for Sustainable Medicine is leading the charge to a net-zero healthcare future. 🌱 Join the discussion with Prof Nick Watts, Director, Centre for Sustainable Medicine, NUS on Monday, 15 July at 5pm! This talk will be held at NCCS and is open to all healthcare professionals. Sign up here: https://for.sg/15jultalk

Congratulations to NCCS winners at the CHI - Centre for Healthcare Innovation X SIT Healthcare Sustainability Innovation Challenge! We are incredibly proud of this achievement! 🎉🎉🎉

Congratulations to NCCS Assoc Prof Ann Lee-Lim and collaborators from the National University Hospital on their Genetics in Medicine study! Using data from 232 colorectal cancer patients from Singapore and the United States, the study showed that using popmax, a computational strategy which uses the highest variant frequency in a given population, lessened the misclassification of germline variants in underrepresented populations with limited data. Read the study here: https://for.sg/4nfl2h

Congratulations Professor Pierce Chow and team on the recent paper published in the British Journal of Cancer! The study summarises possible mechanisms of tumor immune evasion and supports the use of combination and sequential therapies to improve outcomes for patients with primary liver cancer, hepatocellular carcinoma (HCC). Read more here: https://for.sg/yep6hr

Wrapped up a busy week hosting the 62nd Annual Particle Therapy Co-Operative Group (PTCOG) Conference in Singapore, which was attended by more than 1200 international experts from 42 countries! A great week of exchange and sharing best practices. Kudos to our Division of Radiation Oncology team for organising a successful conference.  The final event today saw more than 300 participants visit NCCS for a behind the scenes tour of the Goh Cheng Liang Proton Therapy Centre (GCLPTC), one of the largest radiotherapy centres in Southeast Asia, with five treatment rooms equipped with the real-time image gating system and advanced spot scanning technology to treat complex tumours with high precision. #NCCS25 #frombreakthroughstohealing

We celebrated the Goh Cheng Liang Proton Therapy Centre’s 1st year anniversary and unveiled the recognition wall to honour our donor, Mr Goh Cheng Liang. Thanks to the generosity of the Goh Foundation, which donated $50 million to establish the Goh Cheng Liang Proton Therapy Centre, cancer patients have access to state-of-the-art proton therapy, an advanced form of radiation therapy. #NCCS25 #frombreakthroughstohealing

We had the privilege of hosting Dr Tony Tan, former President of the Republic of Singapore, and Prof Wai Hoe NG, Group CEO, SingHealth at the 62nd Annual Particle Therapy Co-Operative Group (PTCOG) Conference, co-organised by NCCS. Dr. Tony Tan played a pivotal role in bringing proton therapy to Singapore. The introduction of proton therapy significantly enhanced Singapore's medical capabilities, offering a cutting-edge treatment option for cancer patients. At the Conference, Prof Ng delivered a keynote lecture ‘Particle Therapy: A New Hope’, sharing insightful perspectives and visionary outlook on the future of particle therapy and pushing the boundaries of medical science.